ESLA
Estrella Immunopharma (ESLA)
$16
About Estrella Immunopharma (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
$1.35
Daily low
$1.14
Price at open
$1.35
52 Week High
$3.15
52 Week Low
$0.73
Market cap
49.2M
Dividend yield
0.00%
Volume
52,727
Avg. volume
42,499
P/E ratio
-3.16
Estrella Immunopharma News
Details
Daily high
$1.35
Daily low
$1.14
Price at open
$1.35
52 Week High
$3.15
52 Week Low
$0.73
Market cap
49.2M
Dividend yield
0.00%
Volume
52,727
Avg. volume
42,499
P/E ratio
-3.16